Sağlık

Total Market Cap 2,014.6B
P/E (Weighted)Price to Earnings ratio. 41.55 Medyan: 21.29
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 2.76
P/E (Arithmetic)Simple average P/E. 28.46
Avg Lothien ScoreFinancial health score (0-100). 51
Avg DamodaranDamodaran scoring model. 39
Avg PotentialExpected upside potential %. +7.2%
Avg Dalio ScoreDalio debt cycle score. 77
Distributions
Lothien Distribution
0–25
5
25–40
14
40–55
12
55–70
8
70–100
13
Damodaran Distribution
0–25
17
25–40
12
40–55
7
55–70
7
70–100
8
Upside Potential
-100% – -20%
27
-20% – +0%
5
+0% – +20%
6
+20% – +50%
4
+50%+
10

Data date 2026-10-16 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-16
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
1530
14.36 35.9B 3.60 1.12 1.56 60.7% 8.9% 92 89 40.66 +137.3% 98 0.10
3320
4.71 29.6B 6.22 0.49 4.56 10.2% 4.0% 85 82 13.61 +141.6% 50 1.41
2607
11.25 41.7B 6.55 0.46 5.14 8.1% 5.1% 84 75 31.71 +136.4% 61 0.68
3933
7.28 14.3B 5.84 0.70 2.02 16.7% 8.1% 84 81 20.93 +140.7% 81 0.29
1681
15.39 12.9B 10.19 2.42 7.86 29.3% 10.4% 83 75 24.27 +43.3% 99 0.05
1513
21.38 19.0B 10.12 1.21 4.68 21.7% 8.1% 83 84 49.80 +99.7% 84 0.26
0874
13.30 21.6B 7.83 0.47 7.32 5.2% 5.5% 82 68 31.57 +103.1% 59 0.50
1066
3.35 14.9B 7.89 0.53 2.82 7.6% 8.6% 82 70 9.54 +138.5% 84 0.21
0867
10.43 25.2B 7.85 1.20 5.65 6.4% 9.2% 81 42 18.63 +56.6% 93 0.05
2142
9.93 8.2B 11.49 2.86 7.44 155.9% 9.9% 78 75 14.57 +35.1% 93 0.22
0013
21.44 18.7B 5.22 1.93 4.68 -2.5% 9.3% 76 50 50.07 +98.8% 86 0.08
1833
5.82 12.4B 13.51 1.05 9.76 3.8% 10.5% 75 37 8.71 +35.7% 84 0.00
2096
10.83 27.8B 17.60 2.51 10.72 17.1% 9.2% 73 58 11.92 +7.6% 95 0.13
1609
67.20 3.7B 15.76 2.41 13.90 28.3% 11.9% 66 59 60.99 -6.9% 96 0.02
0512
4.63 16.2B 13.07 0.95 8.84 6.8% 8.0% 64 37 6.75 +33.1% 64 0.28
6127
28.16 21.1B 13.99 2.00 15.85 -0.0% 9.5% 64 36 31.87 +8.4% 92 0.00
9989
3.92 5.8B 51.67 0.41 15.46 2.7% 7.0% 63 54 6.99 +58.7% 63 0.24
3759
27.00 49.6B 24.97 2.59 22.11 7.9% 8.5% 60 55 32.59 +15.5% 64 0.43
6821
141.20 50.9B 38.20 2.45 29.01 10.1% 9.5% 57 53 147.08 +3.1% 97 0.02
3692
31.38 190.2B 29.13 4.58 18.77 116.2% 8.5% 57 64 22.92 -20.2% 98 0.00
9969
12.00 21.1B 28.00 2.33 14.76 24.7% 9.1% 55 52 8.72 -20.5% 82 0.17
1801
87.75 153.3B 100.00 6.74 76.24 42.8% 8.4% 54 59 54.38 -28.5% 85 0.15
6160
215.60 316.9B 61.59 7.80 30.99 57.2% 8.4% 54 56 101.17 -39.8% 91 0.22
2276
34.08 16.5B 25.13 5.11 18.78 20.9% 9.4% 52 46 20.21 -30.5% 98 0.11
1276
48.00 318.6B 31.71 4.21 22.78 32.6% 8.5% 51 55 28.16 -31.0% 98 0.00
6699
80.00 13.8B 61.78 3.52 31.75 6.7% 10.5% 49 29 37.66 -39.7% 94 0.03
1952
30.62 10.8B — 1.77 — -4.6% 8.8% 48 34 40.93 +16.2% 65 0.38
3347
41.66 35.9B — 1.57 39.16 2.0% 9.0% 46 35 34.45 -11.1% 79 0.12
0853
6.07 11.6B 30.49 1.51 100.46 -2.4% 7.0% 45 29 4.85 -11.9% 26 1.63
9995
64.85 36.6B 43.82 8.62 29.22 3.4% 9.1% 44 24 22.63 -48.8% 72 0.61
1877
16.18 16.6B — 2.33 — -12.0% 7.9% 43 27 16.18 +0.0% 55 0.69
2637
163.20 12.8B 61.72 6.86 49.13 16.3% 10.5% 42 32 48.72 -52.6% 96 0.07
2696
50.15 27.3B 28.03 5.85 19.36 9.7% 8.5% 41 31 26.14 -34.5% 57 0.91
2228
5.89 25.3B 100.00 2.30 74.60 -6.2% 9.4% 40 13 2.92 -32.3% 82 0.05
6887
38.50 22.2B 69.26 4.34 19.50 4.6% 8.2% 38 25 16.17 -41.8% 42 1.08
1548
31.60 71.1B — 2.29 — 5.4% 9.4% 38 37 24.90 -11.9% 79 0.07
2675
31.20 12.1B — 8.58 — -7.7% 10.5% 36 21 8.49 -34.9% 86 0.01
1672
5.78 6.0B — 2.66 — -72.6% 10.5% 34 12 5.02 -6.4% 85 0.00
2252
21.18 21.8B — 45.25 — -77.2% 9.4% 31 5 5.29 -36.0% 72 1.00
2617
9.14 2.9B — 5.84 — — — 31 — 3.32 -30.5% 87 0.00
7630
13.05 3.7B — 4.05 — -20.7% 12.0% 31 11 6.88 -22.7% 82 0.01
9887
40.66 7.9B — 5.30 — -41.9% 10.2% 31 14 17.66 -27.1% 82 0.22
2162
76.15 22.4B — 6.88 — -12.6% 9.2% 30 19 25.57 -31.9% 79 0.28
6990
438.40 102.2B — 16.35 — -12.3% 8.5% 30 9 109.60 -36.0% 86 0.02
9688
17.95 20.2B — 4.25 — -87.2% 8.8% 27 20 9.30 -23.1% 61 0.42
9606
153.30 13.7B — 4.81 — -29.2% 10.4% 26 19 58.34 -29.7% 80 0.06
2595
27.18 9.6B — 4.48 — -27.2% 10.4% 25 11 9.86 -30.6% 84 0.06
3696
37.64 22.0B — 5.13 — -24.8% 9.5% 23 13 15.19 -28.6% 83 0.04
2493
18.94 8.5B — 8.26 — -51.7% 8.3% 20 14 4.74 -32.3% 33 3.78
2616
4.70 7.5B — 10.29 — -139.3% 10.1% 20 11 1.18 -36.0% 61 0.57
2630
80.40 13.4B — 25.58 — -34.5% 10.1% 16 0 20.10 -32.2% 53 1.45
6855
28.02 10.5B — 16.03 — -112.1% 8.9% 14 9 7.00 -32.3% 31 3.76

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.